Oral contraceptive regimen

Details for Australian Patent Application No. 2008231744 (hide)

Owner Laboratoire Theramex

Inventors Thomas, Jean-Louis

Agent Spruson & Ferguson

Pub. Number AU-A-2008231744

PCT Pub. Number WO2008/116873

Priority 60/920,326 26.03.07 US

Filing date 26 March 2008

Wipo publication date 2 October 2008

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/116873 Priority application(s): WO2008/116873

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231749-Hafnia phytase

2008231738-Predictive renal safety biomarkers and biomarker signatures to monitor kidney function